Feb. 23 at 5:57 PM
$SINT Back when Sint was merely an ortho company its valuation was around 225 (this is what it tried to IPO for in 2007). I can say this because a similar materials company was acquired for about 232m (Implex). Having said that, Sintx Si3N4 provides significantly more benefits than Implex's Hydrocel including the ability to pass those benefits to other materials through coating/infusion. Keep in mind that the market size is over three times it was back then and AP market is even larger.
"Comparable Transactions (Precedent Transactions): Focuses on acquisition prices or valuation multiples from recent mergers and acquisitions of similar companies."
